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background:  Perioperative clopidogrel use increases bleeding risk and blood transfusion requirement of off-pump coronary artery bypass 
graft surgery (OPCAB). This study determined optimal preoperative clopidogrel discontinuation timing based on rates of major bleeding, 
perioperative ischemic events and long-term outcomes.
methods:  Comparison of major bleeding rates at consecutive days between groups A (675 patients off clopidogrel 7 days) identified day 4 
pre-OPCAB as clopidogrel discontinuation cutoff to avoid increased bleeding risk. Primary (major bleeding, reoperation, and multiple-type 
blood transfusions), and secondary (in hospital ischemic events [acute myocardial infarction/stroke], and in-hospital and 1-year mortality) 
outcomes were compared among propensity score-matched subgroups A1 (1-4 days off drug) and A2 (5-7 days), and group B. Predictors 
of post-OPCAB major bleeding were determined by multivariable regression analysis.
Results:  Relative to group B, only subgroup A1 but not subgroup A2 was at increased risk for major bleeding (odds ratio: 1.666 [95% 
confidence interval=1.093-2.541], p=0.018), reoperation (3.747 [1.171-11.982], p= 0.026) and multiple-type blood transfusion (1.929 [1.440-
2.583], p<0.001). Subgroup A1 timing, weight, systolic blood pressure, and low ejection fraction were predictors for major bleeding. In-
hospital ischemic event and 1-year mortality rates did not differ significantly among groups.
conclusion:  A minimal 4-day waiting period post clopidogrel discontinuation appears optimal before OPCAB to minimize bleeding risk. 
This cutoff was further substantiated by meta-analysis of published studies.
